Literature DB >> 18362928

Transduction properties of adenovirus serotype 35 vectors after intravenous administration into nonhuman primates.

Fuminori Sakurai1, Shin-ichiro Nakamura, Kimiyo Akitomo, Hiroaki Shibata, Keiji Terao, Kenji Kawabata, Takao Hayakawa, Hiroyuki Mizuguchi.   

Abstract

Adenovirus serotype 35 (Ad35) vectors have shown promise as effective gene delivery vehicles. However, the transduction profiles of Ad35 vectors in conventional mice allow only a limited estimation of transduction properties of these vectors, because the mouse analog of the subgroup B Ad receptor, CD46, is restricted to the testis. In order to assess the transduction properties of Ad35 vectors more completely, we performed transduction experiments using cynomolgus monkeys, which ubiquitously express CD46 in a pattern similar to that in humans. In vitro transduction experiments demonstrated that cultured cells from the cynomolgus monkey were efficiently transduced with Ad35 vectors. In contrast, after intravenous administration into live monkeys hardly any evidence of Ad35 vector-mediated transduction was found in any of the organs, although Ad35 vector genomes were detected in various organs. Less severe histopathological abnormalities were found in the Ad35 vector-infused monkeys than in the conventional Ad5 vector-injected monkeys. In the latter, serious tissue damage and inflammatory responses, such as hepatocyte necrosis and lymphatic hyperplasia in the colon, were induced. Both Ad35 and Ad5 vectors caused similar hematological changes (increase in CD3(+) cells, and decrease in CD16(+) cells and CD20(+) cells) in peripheral blood cells. These results should provide valuable information for the clinical application of Ad35 vectors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362928     DOI: 10.1038/mt.2008.19

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  15 in total

1.  NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo.

Authors:  Masataka Suzuki; Racel Cela; Terry K Bertin; Gautam Sule; Vincenzo Cerullo; John R Rodgers; Brendan Lee
Journal:  Hum Gene Ther       Date:  2011-07-08       Impact factor: 5.695

Review 2.  In Vivo Hematopoietic Stem Cell Transduction.

Authors:  Maximilian Richter; Daniel Stone; Carol Miao; Olivier Humbert; Hans-Peter Kiem; Thalia Papayannopoulou; André Lieber
Journal:  Hematol Oncol Clin North Am       Date:  2017-10       Impact factor: 3.722

3.  Macropinocytotic uptake and infection of human epithelial cells with species B2 adenovirus type 35.

Authors:  Stefan Kälin; Beat Amstutz; Michele Gastaldelli; Nina Wolfrum; Karin Boucke; Menzo Havenga; Fabienne DiGennaro; Nicole Liska; Silvio Hemmi; Urs F Greber
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

Review 4.  Adenoviral vector immunity: its implications and circumvention strategies.

Authors:  Yadvinder S Ahi; Dinesh S Bangari; Suresh K Mittal
Journal:  Curr Gene Ther       Date:  2011-08       Impact factor: 4.391

5.  In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors.

Authors:  Maximilian Richter; Kamola Saydaminova; Roma Yumul; Rohini Krishnan; Jing Liu; Eniko-Eva Nagy; Manvendra Singh; Zsuzsanna Izsvák; Roberto Cattaneo; Wolfgang Uckert; Donna Palmer; Philip Ng; Kevin G Haworth; Hans-Peter Kiem; Anja Ehrhardt; Thalia Papayannopoulou; André Lieber
Journal:  Blood       Date:  2016-08-23       Impact factor: 22.113

6.  A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapy.

Authors:  Hongjie Wang; Ying Liu; Zong-Yi Li; Xiaolong Fan; Akseli Hemminki; André Lieber
Journal:  Blood       Date:  2009-11-12       Impact factor: 22.113

7.  Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents.

Authors:  Elena V Shashkova; Shannon M May; Michael A Barry
Journal:  Virology       Date:  2009-09-18       Impact factor: 3.616

8.  Epithelial Junction Opener Improves Oncolytic Adenovirus Therapy in Mouse Tumor Models.

Authors:  Roma Yumul; Maximilian Richter; Zhuo-Zhuang Lu; Kamola Saydaminova; Hongjie Wang; Chung-Huei Katherine Wang; Darrick Carter; André Lieber
Journal:  Hum Gene Ther       Date:  2016-04       Impact factor: 5.695

9.  Transduction of liver metastases after intravenous injection of Ad5/35 or Ad35 vectors with and without factor X-binding protein pretreatment.

Authors:  Ying Liu; Hongjie Wang; Roma Yumul; Wentao Gao; Andrea Gambotto; Takashi Morita; Andrew Baker; Dmitry Shayakhmetov; André Lieber
Journal:  Hum Gene Ther       Date:  2009-06       Impact factor: 5.695

10.  In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46.

Authors:  Hongjie Wang; Ying Liu; Zongyi Li; Sebastian Tuve; Daniel Stone; Oleksandr Kalyushniy; Dmitry Shayakhmetov; Christophe L M Verlinde; Thilo Stehle; John McVey; Andrew Baker; Kah-Whye Peng; Steve Roffler; André Lieber
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.